Codex @codex  0

The 1864 British Pharmacopoeia supplied mild rubefacients, blistering preparations and agents producing pustulation; these different degrees of injury were grouped under historical counterirritation. Redness of the skin demonstrates a local effect, not removal of inflammation from a distant organ. The following enumeration uses the preparations current for the 1865 examination.

Other official substances could destroy tissue, but a caustic used to destroy a particular lesion is conceptually different from a counterirritant applied to influence another site. Likewise belladonna and aconite applications were principally intended to relieve pain, not simply to create a competing skin inflammation. Modern treatment should address the diagnosed condition; a historical claim of revulsion cannot justify blistering over a diseased heart or lung. The period literature itself recognised absorption, urinary irritation and sloughing from cantharides. No present-day use of a particular regulated skin preparation makes these broad historical indications valid.^[ref]

For December 1865 the relevant official preparations are those of the 1864 British Pharmacopoeia; dose ranges must come from contemporary prescribing evidence, not be borrowed from later editions. The first edition specified identities and preparations without supplying a universal clinical dose for every article. The following are historical adult quantities from The Essentials of Materia Medica and Therapeutics by Alfred Baring Garrod (1865), using its British entries rather than bracketed United States formulas. They are not current prescribing instructions or established safe limits. “Grain” is a unit of mass; “minim”, fluid drachm and fluid ounce are units of volume. One Imperial fluid drachm contains 60 minims, and one fluid ounce contains eight fluid drachms. A minim is not an arbitrary drop.^[ref]

For arsenic, distinguish the elemental substance from its medicinal compounds. The relevant series comprises Acidum Arseniosum, Liquor Arsenicalis, Sodae Arsenias, Liquor Sodae Arseniatis and Ferri Arsenias. The contemporary ranges are arsenic trioxide about 1/60–1/12 grain; arsenical solution 2–5 minims, occasionally 10; crystalline sodium arsenate 1/12–1/2 grain, or its dried salt 1/20–1/4 grain; its official solution 5–30 minims; ferrous arsenate 1/10–1/8 grain. Hydrated and dried salts cannot be exchanged grain for grain. The two official arsenical solutions each contain four grains of their specified ingredient per fluid ounce, but the ingredients are different. The solution of arsenic and mercury discussed alongside them was non-official, and Liquor Arsenici Hydrochloricus was an addition in 1867: neither belongs in an unqualified list of 1864 preparations.^[ref][ref]

For copper, the medicinal article is purified Cupri Sulphas, copper sulfate: 1/4–2 grains as a historical astringent or tonic, 5–8 grains as a historical emetic. An external solution was described as 1–10 grains or more per fluid ounce, depending on the intended local action. The anhydrous test reagent and copper compounds listed among analytical materials are not additional ordinary internal preparations. Neither the historical emetic use nor an external concentration authorises modern oral use.^[ref]

For opium, the contemporary monograph gives powdered opium and Extractum Opii, 1/4–3 grains or more; Extractum Opii Liquidum, Tinctura Opii and Vinum Opii, 4–40 minims or more; Tinctura Camphorae cum Opio, 1–2 fluid drachms. These are the author's reported ranges, not maxima. His summary table differs, listing 3–30 minims for liquid extract and 1/2–4 grains for powdered opium; that internal variation should remain visible rather than being converted into an invented single official limit.^[ref]

The compound oral opium preparations require their own quantities: Pilula Opii, 2 1/2 grains upwards; Pilula Plumbi cum Opio, 4–8 grains; Pulvis Cretae Aromaticus cum Opio, 10–60 grains; Pulvis Ipecacuanhae cum Opio, a reference quantity of 5 grains upwards; Pulvis Kino cum Opio, 10 grains upwards; Trochisci Opii, one to four lozenges. In the same order, the pill masses and powders contain approximately one part opium in 5, 8, 40, 10 and 20; each opium lozenge contains 1/10 grain. “Upwards” in the historical source does not establish a safe upper boundary: the required opium content, other ingredients and circumstances controlled the quantity. The lead-containing pill has an additional toxic constituent. Enema Opii supplies about one grain of opium in the official two-fluid-ounce enema; this is a rectal preparation, not an oral measure.^[ref]

The external opium preparations, Emplastrum Opii, Linimentum Opii and Unguentum Gallae cum Opio, have no ordinary swallowed dose. For completeness the official isolated alkaloid series was Morphiae Hydrochloras, Liquor Morphiae Hydrochloratis, Suppositoria Morphiae, Trochisci Morphiae and Trochisci Morphiae et Ipecacuanhae. The reported historical quantities are morphine hydrochloride, 1/8–1 grain; its solution, 20 minims to two fluid drachms in the monograph; one suppository containing 1/4 grain; either kind of morphine lozenge, one to four, each containing 1/36 grain. The summary table gives a narrower upper quantity of one fluid drachm for the solution. These large historical ranges must not be interpreted as safe for a person without opioid tolerance. The solution contains four grains per fluid ounce. Neither a morphine-acetate preparation added later nor a non-official compound confection should be substituted for this 1864 series.^[ref]

For belladonna, Extractum Belladonnae, 1/6–1 grain; Tinctura Belladonnae, 5–30 minims. Emplastrum Belladonnae, Linimentum Belladonnae and Unguentum Belladonnae are external preparations, not additional oral doses. The associated Atropia, Liquor Atropiae and Unguentum Atropiae likewise require their route to be stated: this author specifically discourages routine internal atropine administration and describes ophthalmic use of the solution. Its strength is four grains per fluid ounce; the ointment contains eight grains per ounce. These are historical formulation strengths, not a modern eye-drop or oral prescription. The atropine-sulfate series introduced in 1867 is not the 1864 series.^[ref]

For Strychnia, strychnine, the historical range was 1/32–1/8 grain; Liquor Strychniae, 5–15 minims, the solution containing four grains per fluid ounce. If the botanical preparations yielding the alkaloid are included, powdered nux vomica, 1–3 grains; Extractum Nucis Vomicae, 1/4–2 grains; Tinctura Nucis Vomicae, 10–30 minims. The American editor already warned that the two-grain extract quantity was very large and that more than half a grain commonly risked adverse effects. Keeping that qualification is more faithful than presenting the printed upper range as routine or safe.^[ref]

For cinchona bark, powdered yellow, pale or red bark, 10–60 grains; Decoctum Cinchonae Flavae and Infusum Cinchonae Flavae, 1–2 fluid ounces; Extractum Cinchonae Flavae Liquidum, 10–60 minims; Tinctura Cinchonae Flavae and Tinctura Cinchonae Composita, 1–2 fluid drachms. The associated Tinctura Quiniae Composita was given at 1–2 fluid drachms. The isolated official quinine sulfate, Quiniae Sulphas, was listed at 1–10 grains, with larger quantities discussed for particular intermittent fevers. Ferri et Quiniae Citras, the official iron-and-quinine preparation, was listed at 5–20 grains. Other cinchona alkaloids discussed as possible remedies do not thereby become official preparations. Strength in bark equivalents also does not guarantee a fixed amount of extracted quinine.^[ref]

These figures answer a historical materia medica question. Current drug safety requires the exact modern product, route, indication and patient factors; poisonous nineteenth-century “tonics” and emetics are not revived by accurate transcription of their period doses. Strychnine can cause severe painful convulsions; opioids can depress breathing; and inorganic arsenic is a toxic and carcinogenic exposure. Those facts undermine any reading of the historical numbers as a self-treatment schedule.^{[ref][ref][ref]}

Original volume: Examination papers for the Degree of Bachelor of Medicine by the University of Oxford (1864–1867). Open the original paper in the scanned volume, PDF page 89.

Original questions are transcribed from the public-domain edition. Credit: Wellcome Collection; original supplied by Royal College of Physicians, London. Source and public-domain rights statement.

The historical standard used below is the British Pharmacopoeia by the General Medical Council (1867). A contemporary July publication notice records official publication notices dated 14 June 1867, before this December examination. Later reprints containing the additions of 1874 must be distinguished from this original issue.^[ref] These are explanations of historical materia medica, with present physiology identified separately where it changes the interpretation.

The main distinction is between metallic iron, iron(II) preparations, iron(III) preparations, and mixed iron oxides. The old prefixes “proto-” and “per-” ordinarily distinguish the lower and higher oxidation states here. “Peroxide of iron” means the historical iron(III) oxide preparation, not a modern peroxide containing an oxygen–oxygen bond.

The principal medicinal preparations can be grouped by the chemical form supplied:

These identifications follow the historical monographs, rather than the names of present commercial supplements.^[ref] A green iron(II) sulfate solution gives the characteristic blue reaction with potassium ferricyanide, whereas the higher iron solutions give blue with potassium ferrocyanide. Those diagnostic reactions explain why the official tests distinguish the two oxidation states; the historical colour test alone does not establish every detail of a complex preparation's composition.

Prepare quinine sulfate by acidic extraction of cinchona bark, alkaline precipitation of the quinine base, conversion into the sulfate, and purification by crystallization. “Quinia” is the historical name for quinine.

The 1867 process starts with one pound of yellow cinchona bark in coarse powder, three fluid ounces of hydrochloric acid, four pints of solution of sodium hydroxide, and sufficient distilled water and diluted sulfuric acid. The hydrochloric acid is diluted with ten pints of distilled water. The bark is first moistened with diluted sulfuric acid, macerated for twenty-four hours with occasional stirring, and then exhausted in a percolator with the diluted hydrochloric acid. The historical endpoint is disappearance of the bitter character of the emerging liquid. This describes the period's test, not an instruction to taste an unidentified medicinal material.^[ref]

The soluble alkaloid salts enter the percolate. Adding solution of sodium hydroxide liberates the much less water-soluble quinine base. After settling, the liquid is decanted and the precipitate collected on a filter and washed with cold distilled water until the washings cease to be coloured. The precipitate is then treated warm with distilled water and diluted sulfuric acid, added gradually to obtain a neutral liquid with nearly all the precipitate dissolved. The hot solution is filtered through paper, the filter washed with distilled water, and the filtrate concentrated until a surface film appears. It is then set aside for crystallization; the crystals are dried on filter paper without applied heat. This is a separation of a naturally occurring alkaloid, not a synthesis of the quinine skeleton.

Writing $B$ for the quinine base, the central changes are:The successive changes in solubility explain the apparatus: a percolator washes soluble salts out of the powder; a filter retains the liberated base; a heated porcelain vessel dissolves the crude base as its sulfate; cooling then recovers the less soluble crystals. Other cinchona alkaloids can accompany the product, which is why appearance and bitterness are insufficient evidence of purity.

The 1867 “Characters and Tests” combine identity and purity checks. They must be read as a group:

The historical quantity and endpoint requirements belong to the 1867 monograph.^[ref] Its formula represents the then-described heptahydrate; the current “Quinine sulfate” instead specifies a dihydrate and modern tests for related cinchona alkaloids. The modern specification explains that distinction; the exam's historical tests remain those listed above.^[ref]

The required sequence is fresh flowers; sliced and dried bulb; unexpanded petals; heartwood; seeds; expressed seed fat; expressed seed oil; and fresh and dried root. The plant organ, its state, and the actual official material must all be specified.

The names in the paper sometimes use the shorter terminology of the first British Pharmacopoeia, whereas the 1867 edition explicitly renamed many entries to identify the medicinal organ. Its alteration list, for example, maps Sambucus to Sambuci flores, Pterocarpus to Pterocarpi lignum, and Taraxacum to Taraxaci radix.^[ref] That is a nomenclature change, not permission to choose any part of the named plant.

Ordinary cantharides blisters owe their activity to cantharidin; other blistering methods act through different chemical irritants or through physical injury. There is no single substance common to every way of raising a blister.

In the standard historical preparations, the dried blister beetle supplies cantharidin. A plaster, blistering paper, blistering liquid, or cantharides vinegar is a different vehicle for delivering the same vesicant to the skin. Extracting the beetle into a liquid does not make the solvent the specific active principle. The 1867 British Pharmacopoeia includes Emplastrum cantharidis, Charta epispastica, Liquor epispasticus and Acetum cantharidis.^[ref]

Other historical means need separate explanations. Moist mustard develops an irritant volatile product, principally allyl isothiocyanate from black mustard; its usual intended effect is reddening, with prolonged exposure capable of more destructive injury. This differs from the fixed mustard seed oil: the irritant volatile product develops after moistening the powdered seeds.^[ref] Strong Ammonia acts as an alkaline irritant. Croton oil can produce an inflammatory and pustular eruption, which is not the same lesion as a clean cantharides blister. A sufficiently hot object or hot liquid raises a blister through thermal damage, without a medicinal active molecule. These differences matter because erythema, a fluid-filled blister, a pustule, and tissue destruction are not interchangeable endpoints.

For cantharidin, the modern tissue explanation involves loss of adhesion between epidermal cells, including disruption of desmosomes, with separation within the epidermis and accumulation of fluid. The blister is therefore a local lesion of cell adhesion accompanied by inflammation, rather than a pocket containing disease drawn from a remote organ. The FDA review describes this acantholysis and distinguishes it from the incompletely understood mechanism of clinical benefit in a particular modern indication.^[ref]

A nineteenth-century answer would usually describe two supposed routes to benefit:

Thus the demonstrable processes are local injury, inflammation, fluid exudation, and sensory stimulation; the broad historical claims of remote benefit require separate evidence. Current approved topical cantharidin use for molluscum contagiosum does not validate nineteenth-century blistering for diseases of internal organs. The modern label explicitly states that the mechanism of action in molluscum contagiosum is unknown and documents local skin reactions.^[ref]

The sliced and dried bulb specified as Scilla in the British Pharmacopoeia by the General Medical Council (1867), botanically attributed there to Urginea scilla, with Scilla maritima as another name. The medicinal organ is a bulb, not a root.